
Stock Movers Pfizer Gains, CoreWeave Climbs, Firefly Aerospace Plunges on Rocket Explosion
Sep 30, 2025
Pfizer experiences a stock surge due to an anticipated agreement with the Trump administration to lower drug prices for Medicaid. Meanwhile, CoreWeave’s shares soar after landing a massive computing contract with Meta, enhancing their market position. In a stark contrast, Firefly Aerospace faces a significant setback as a rocket explosion during testing leads to a 25% decline in stock value, jeopardizing their upcoming launch schedule. Tune in for all the market-moving details!
AI Snips
Chapters
Transcript
Episode notes
Pfizer Rallies On Tariff Reprieve
- Pfizer stock jumped after reports of a three-year reprieve from proposed pharma tariffs tied to a White House agreement.
- The market reacted strongly with Pfizer posting its biggest intraday gain since May 2024.
Price Cuts Paired With Political Messaging
- The reported deal includes selling some drugs at about a 50% discount via a Trump-branded site and changes to distribution.
- The move mixes policy and pricing strategy, and broad industry peers also rose on the news.
CoreWeave Lands Major Meta Compute Deal
- CoreWeave shares surged after signing a deal to supply Meta up to $14.2 billion of compute through 2031 with an extension option.
- The deal diversifies CoreWeave beyond Microsoft and highlights intense demand for AI compute.
